Dietary soya protein during pregnancy and lactation in rats with hereditary kidney disease attenuates disease progression in offspring

British Journal of Nutrition

Volumn 97, Issue 1, 2007, Pages 77-84

  Cahill, Leah E ^a   Peng, Claudia Yu Chen ^a   Bankovic Calic, Neda ^a   Sankaran, Deepa ^a   Ogborn, Malcolm R ^a,b   Aukema, Harold M ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MANITOBA INSTITUTE OF CHILD HEALTH   (Canada)

Author keywords

Kidney disease; Maternal nutrition; Rats; Soya protein

Indexed keywords

CASEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SOYBEAN PROTEIN; BIOLOGICAL MARKER; CYCLINE; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL INFILTRATION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DIET THERAPY; DISEASE COURSE; FEMALE; IMMUNOHISTOCHEMISTRY; KIDNEY CELL; KIDNEY DISEASE; KIDNEY FUNCTION; LACTATION; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PREGNANCY; PROGENY; PROTEIN DIET; PROTEINURIA; RAT; RAT STRAIN; WEANING; ANIMAL; ARTICLE; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; EMBRYO DEVELOPMENT; IMAGE PROCESSING; KIDNEY; MATERNAL NUTRITION; METABOLISM; METHODOLOGY; PATHOLOGY; PREGNANCY COMPLICATION; PRENATAL DEVELOPMENT; UREMIA;

ANIMALIA; RATTUS;

ANIMALS; BIOLOGICAL MARKERS; CASEINS; CELL PROLIFERATION; DISEASE PROGRESSION; EMBRYONIC DEVELOPMENT; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS, LDL; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL NUTRITION PHYSIOLOGY; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEINURIA; RATS; RATS, INBRED STRAINS; SOYBEAN PROTEINS; UREMIA; WEANING;

EID: 33847136883     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507250470     Document Type: Conference Paper

References (50)

1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M & Fukami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262, 5592-5595.
2. American Institute of Nutrition (1993) AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951.
3. Aukema HM & Housini I (2001) Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats. Kidney Int 59 52-61.
4. Aukema HM, Housini I & Rawling JM (1999) Dietary soy protein effects on inherited polycystic kidney disease are influenced by gender and protein level. J Am Soc Nephrol 10, 300-308.
5. Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, Mehrabi Y & Esmaill-Zadeh A (2003) Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr 57, 1292-1294.
6. Barker DJ & Bagby SP (2005) Developmental antecedents of cardiovascular disease: A historical perspective. J Am Soc Nephrol 16, 2537-2544.
7. Barsotti G, Morelli E, Cupisti A, Bertoncini P & Giovannetti S (1991 A special, supplemented 'vegan' diet for nephrotic patients. Am J Nephrol 11, 380-385.
8. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
9. Branham WS, Dial SL, Moland CL, Hass BS, Blair RM, Fang H, Shi L, Tong W, Perkins RG & Sheehan DM (2002) Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor. J Nutr 132, 658-664.
10. Bosch J, Saccaggi A, Lauer A, Ronco C, Belledonne M & Glabman S (1983) Renal functional reserve in humans. Effect of protein intake on glomerular filtration rate. Am J Med 75, 943-950.
11. Chen S, Peng S & Chen J (2003) Effects of dietary protein on renal function and lipid metabolism in five-sixths nephrectomized rats. Brit J Nutr 133, 673-678.
12. Choukroun G, Itakura Y, Albouze G, Christophe JL, Man NK, Grunfeld JP & Jungers P (1995) Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 6, 1634-1642.
13. Cowley BD Jr, Gudapaty S, Kraybill AL, Barash BD, Harding MA, Calvet JP & Gattone VH 2nd (1993) Autosomal-dominant polycystic kidney disease in the rat. Kidney Int 43, 522-534.
14. Cowley BD Jr, Rupp JC, Muessel MJ & Gattone VH 2nd (1997) Gender and the effect of gonadal hormones on progression of inherited polycystic kidney disease in rats. Am J Kidney Dis 29, 265-272.
15. D'Amico G, Remuzzi G, Maschio G, Gentile MG, Gotti E, Oldrizzi L, Manna G, Mecca G, Rugiu C & Fellin G (1991) Effects of dietary proteins and lipids in patients with membranous nephrology and nephrotic syndrome. Clin Nephrol 6, 237-242.
16. Fair DE, Ogborn MR, Weiler HA, Bankovic-Calic N, Nitschmann EP, Fitzpatrick-Wong SC & Aukema HM (2004) Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han:SPRD-cy weanling rats. J Nutr 134, 1504-1507.
17. Fritz WA, Coward L, Wang J & Lamartiniere CA (1998) Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 19, 2151-2158.
18. Gentile M, Fellin G, Cofano F, Delle Fave A, Manna G, Ciceri R, Petrini C, Lavarda F, Pozzi F & D'Amico G (1993) Treatment of proteinuric patients with vegetarian soy diet and fish oil. Clin Nephrol 40 315-320.
19. Gretz N, Ceccherini I, Kranzlin B, Kloting I, Devoto M, Rohmeiss P, Hocher B, Waldherr R & Romeo G (1995) Gender-dependent disease severity in autosomal polycystic kidney disease of rats. Kidney Int 48 496-500.
20. Heinegard D & Tiderstrom. G (1973) Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta 43, 305-310.
21. Hostetter T (2003) Prevention of the development and progression of renal disease. J Am Soc Nephrol 14, S 144-S147.
22. Hwang J, Wang J, Morazzoni P, Hodis HN & Sevanian A (2003) The phytoestrogens equol increases nitric oxide availability by inhibiting superoxide production: An antioxidant mechanism for cell mediated LDL modification. Free Radic Biol Med 34, 1271-1282.
23. Iwasaki K, Gleiser CA, Masoro EJ, McMahan CA, Seo EJ & Yu BP (1988) The influences of dietary soy protein on longevity and age-related disease processes of Fischer rats. J Gerontol 43, B5-B12.
24. Jackson AA, Dunn RL, Marchand MC & Langley-Evans SC (2002) Increased systolic blood pressure in rats induced by a maternal low-protein diet is reversed by dietary supplementation with glycine. Clin Sci (Lond 103, 633-639.
25. Jibani MM, Bloodworth LL, Foden E, Griffiths KD & Galpin OP (1991) Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: Effects on albumin excretion rate and nutritional status. Diabet Med 8, 949-953.
26. Knight E, Stampfer M, Hankinson S, Spiegelman D & Curhan G (2003) The impact of protein on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med 138, 460-467.
27. Kontessis P, Jones S, Dodds R, Trevisan R, Nosadini R, Fioretto P, Borsato M, Sacerdoti D & Viberti G (1990) Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int 38, 136-144.
28. Langley-Evans SC, Welham SJM & Jackson AA (1999) Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat. Life Sci 64, 965-974.
29. Lillycrop KA, Phillips ES, Jackson AA, Hanson MA & Burdge GC (2005) Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr 135, 1382-1386.
30. Linz AL, Xiao R, Parker JG, Simpson PM, Badger TM & Simmen FA (2004) Feeding of soy protein isolate to rats during pregnancy and lactation suppresses formation of aberrant crypt foci in their progeny's colons: interaction of diet with fetal alcohol exposure. J Carcinog 3 14-28.
31. Markovits J, Linassier C, Fosse P, Couprie I, Pierre J, Jacquemini-Sablon A, Saucier JM, Le Pecq JB & Larsen AK (1989) Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49, 5111-5117.
32. Meguid El Nahas A & Bello AK (2005) Chronic kidney disease: The global challenge. Lancet 365, 331-340.
33. Ogborn MR, Bankovic-Calic N, Shoesmith C, Buist R & Peeling J (1998) Soy protein modification of rat polycystic kidney disease. Am J Physiol 274, F541-F549.
34. Ogborn MR, Nitschmann E, Bankovic-Calic N, Weiler H & Aukema H (2005) Flax and soy phytoestrogen effects on renal injury and lipid content in experimental polycystic kidney disease. J Am Nutraceut Assoc 8 26-32.
35. Ogborn MR, Nitschmann E, Weiler HA & Bankovic-Calic N (2000) Modification of polycystic kidney disease and fatty acid status by soy protein diet. Kidney Int 57, 159-166.
36. Pedraza-Chaverri J, Barrera D, Hernandez-Pando R, Medina-Campos ON, Cruz C, Murguia F, Juarez-Nicolas C, Correa-Rotter R, Torres N & Tovar AR (2004) Soy protein diet ameliorates renal nitrotyrosine formation and chronic nephropathy induced puromycin aminonucleoside. Life Sci 74, 987-999.
37. Regnault TR, Friedman JE, Wilkening RB, Anthony RV & Hay WW Jr (2005) Fetoplacental transport and utilization of amino acids in IUGR - a review. Placenta 19, S52-S62.
38. Ryokkynen A, Kukkonen JV & Nieminen P (2005) Effects of dietary genistein on mouse reproduction, postnatal development and weight-regulation. Anim Reprod Sci 93, 337-348.
39. Setchell KD, Clerici C, Lephart ED, et al. (2005) S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 81, 1072-1079.
40. Stephenson TJ, Setchell KD, Kendall CW, Jenkins DJ, Anderson JW & Fanti P (2005) Effect of soy protein-rich diet on renal function in young adults with insulin-dependent diabetes mellitus. Clin Nephrol 64, 1-11.
41. Teixeira S, Tappeneden K, Carson L, Jones R, Prabhudesai K, Marshell W & Erdman J Jr (2004) Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 Diabetes Mellitus and nephropathy. J Nutr 134, 1874-1880.
42. Teixeira S, Tappenden K & Erdman J (2003) Altering dietary protein type and quantity reduces urinary albumin excretion without affecting plasma glucose concentration in BKS.cg-m + Lepr db (db/db) mice. J Nutr 133, 673-678.
43. Tomobe K, Philbrick DJ, Ogborn MR, Takahashi H & Holub BJ (1998) Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease. Am J Kidney Dis 31, 55-61.
44. Trujillo J, Ramirez V, Perez J, Torre-Villalvazo I, Torres N, Tovar AR, Munoz RM, Uribe N, Gamba G & Bobadilla NA (2005) Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation. Am J Physiol Renal Physiol 288, F108-F116.
45. Vehaskari VM & Woods LL (2005) Prenatal programming of hypertension: lessons from experimental models. J Am Soc Nephrol 16, 2545-2556.
46. Wang D, Braendstrup O, Larsen S, Horn T & Strandgaard S (2004) The expression and activity of renal nitric oxide synthase and circulating nitric oxide in polycystic kidney disease rats. APMIS 112, 358-368.
47. Williams A & Wallis J (1987a) Metabolic consequences of differing protein diets in experimental renal disease. Eur J Clin Invest 17, 117-122.
48. Williams A & Wallis J (1987b) Effect of varying quantity and quality of dietary protein intake in experimental renal disease in rats. Nephron 46, 83-90.
49. Zerres K, Volpel MC & Weiss H (1984) Cystic kidneys: Genetics, pathologic anatomy, clinical picture, and prenatal diagnosis. Hum Genet 68, 104-135.
50. Zandi-Nejad & Luyckx VA & Brenner BM (2006) Adult hypertension and kidney disease: The role of fetal programming. Hypertension 47 502-508.